Literature DB >> 2324511

A specific, sensitive radioimmunoassay for platelet-activating factor (PAF).

M A Smal1, B A Baldo, A McCaskill.   

Abstract

A specific radioimmunoassay (RIA) has been developed for platelet-activating factor (PAF) and shown to be sensitive over the range 10-1000 pg (0.02-2 pmol). The anti-PAF antibodies showed specificity for the acetyl group at the C2 position of the PAF molecule and exhibited no significant cross-reactivity with lyso-PAF or the naturally occurring lipids including lecithin and lysolecithin. The sensitivity of the RIA was at least as good as the platelet-based assays for PAF but the RIA was simpler to perform, had a higher capacity and did not have the drawback of the inherent variability associated with the bioassays.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324511     DOI: 10.1016/0022-1759(90)90209-e

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Quantitation by radioimmunoassay of PAF in human saliva.

Authors:  S J Cooney; M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Down-regulation of platelet-activating factor receptor gene expression during focal reversible cerebral ischemia in rats.

Authors:  Xiong Zhang; Xi-Long Pan; Xin-Tong Liu; Shuo Wang; Li-Juan Wang
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

3.  The platelet activating factor as a pivotal mediator of shock after liver ischemia.

Authors:  T Fukuoka; Y Nakajima; H Nakano
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Blood levels of PAF are elevated during induction of immune complex mediated enteropathy in the rat.

Authors:  K J Bloch; B P Ng; M Bloch
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.